Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.4B | $1.6B | $1.7B | -- | |
| Total Assets | $2.6B | $2.7B | $3B | $3.1B | -- | |
| Current Liabilities | $654.1M | $776.9M | $961.6M | $762.6M | -- | |
| Total Liabilities | $1.2B | $1.4B | $1.6B | $1.5B | -- | |
| Total Equity | $1.4B | $1.2B | $1.5B | $1.6B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
Emmi AG engages in the development, production, and marketing of dairy and fresh products. It operates through the following segments: Switzerland, Americas, Europe, and Global Trade. The Americas segment includes the following markets: US, Canada, Chile, Mexico, Spain, France, and Tunisia. The Europe segment incorporates the markets of Italy, Germany, Austria, Belgium, the Netherlands, the United Kingdom, and Lácteos Caprinos S.A. in Spain. The Global Trade segment comprises direct sales from Switzerland to customers in countries in which the company has no subsidiaries. The company was founded on February 6, 1907 and is headquartered in Lucerne, Switzerland.
In the current month, EMLZF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EMLZF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Emmi AG share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Emmi AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Emmi AG is a Sell and believe this share price will rise from its current level to --.
The price target for Emmi AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Emmi AG is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Emmi AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Emmi AG shares.
Emmi AG was last trading at $1,007.96 per share. This represents the most recent stock quote for Emmi AG. Yesterday, Emmi AG closed at $1,007.96 per share.
In order to purchase Emmi AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.